How Do Health Canada Class I Rules Compare With FDA 21 CFR 876.5920 for Incontinence Briefs?

Detail view of the CliniEco brief construction, the product the two regulatory files describe

An adult brief sold in both countries has to satisfy two regulators, and the interesting part of the comparison is that both call it a Class I device while asking for different things. In the United States the obligation runs through 21 CFR 876.5920, which classifies the protective garment for incontinence and exempts it from premarket notification. In Canada the same product is a Class I medical device under the Medical Devices Regulations, which means no device licence is required at all — but an establishment licence is required to import or sell it. The 3,000 mL Day Comfort brief is one of the lines that carries this dual status, and the paperwork that supports it is a useful worked example of what the difference means in practice.

This comparison is written for a procurement or quality manager who buys the same product in both markets and has to hold one file that satisfies both, not for a regulatory submission. It sets out the classification, the premarket requirements, the establishment obligations and the labelling duties in each country.

Are adult briefs the same device class in both countries?

Both jurisdictions place the product in Class I, but they get there by different routes, and the routes explain why the paperwork differs.

The United States classifies by device type. Each type has its own regulation in Title 21, and 876.5920 defines the protective garment for incontinence as a device that "consists of absorbent padding and a fluid barrier and that is intended to protect an incontinent patient's garment from the patient's excreta", then states: "Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9." The same paragraph adds an exemption from the quality management system regulation in part 820, except for the requirements concerning records and complaint files under 820.35.

Canada classifies by risk under the classification rules in the Medical Devices Regulations, and the class then determines which licence applies. The regulation that carries the consequence is section 26: "no person shall import or sell a Class II, III or IV medical device unless the manufacturer of the device holds a licence in respect of that device". Class I is conspicuously absent from that sentence, which is the legal basis for the widely repeated statement that Class I devices do not need a device licence in Canada.

One substitution is worth flagging, because it appears in real procurement documents: 21 CFR 876.5250 is not the brief regulation. It covers urine collectors and accessories — the external sheath, leg bag and paste-on device among them — and it splits its own classification, with Class II special controls for devices intended to connect to an indwelling catheter and Class I for those that are not. A file that cites 876.5250 for an adult brief has cited a real section about a different device, which is the kind of error that survives until an auditor reads it.

The practical difference is that a US file is organised around a device type and its exempting language, while a Canadian file is organised around the class and the establishment that holds the licence. Both files describe the same product; they do not answer the same questions.

What does each regulator require before the product can be sold?

Requirement United States Canada
Device classification Class I under 21 CFR 876.5920 Class I under the Medical Devices Regulations classification rules
Premarket review None — exempt from 510(k) under 876.5920, subject to 876.9 None — section 26 applies a device licence only to Class II, III and IV
Manufacturer registration Foreign establishment registers and lists under 21 CFR 807.40, with a US agent Manufacturer of a Class I device holds an establishment licence, or distributes solely through one that does
Importer or seller licence Registration and listing obligations fall on the establishment; no state-level device licence Establishment licence required to import or sell under section 44(1)
Quality system QMSR exemption for 876.5920 devices, except records and complaint files under 820.35 Class I manufacturer obligations under the regulations, including records and complaint handling
Labelling FDA labelling requirements for the device type Section 21 sets the label contents; bilingual labelling obligations apply in Canada

Three entries in that table are worth a second look. The first is the US quality system exemption: it is real, but it is not a blanket exemption from keeping records, because complaint files and records obligations survive under 820.35. A Canadian manufacturer exporting to the United States should read that sentence before concluding that no quality system obligations apply.

The second is 21 CFR 807.40, which is the requirement most often missed by non-US suppliers. It applies to "any establishment within any foreign country engaged in the manufacture, preparation, propagation, compounding, or processing of a device that is imported or offered for import into the United States", and it requires registration and listing through the FDA electronic system, plus designation of a United States agent who resides or maintains a place of business in the United States. A Class I product with no premarket review still has an establishment obligation on the US side.

The third is the Canadian establishment licence, which is frequently misunderstood by US buyers. Section 44(1) states that no person shall import or sell a medical device unless the person holds an establishment licence, and subsection (2) carves out retailers, health care facilities, and the manufacturer of a Class I device that imports or distributes solely through a person who holds an establishment licence. The consequence for a facility is that the licence number it should record is not the manufacturer's device licence — there isn't one for Class I — but the establishment licence of the party importing or distributing.

What does this mean for a US facility buying from a Canadian supplier?

Four checks, in order. Ask for the FDA establishment registration and listing confirmation, because 807.40 applies to the foreign establishment and not to the product. Ask who the US agent is, since that designation is part of the registration and is the contact FDA will use. Ask which party holds the Canadian establishment licence, because the same company may manufacture in one country and distribute in the other through a different legal entity. And ask for the label as it will appear in each market, because the Canadian label has content requirements under section 21 and the US label does not mirror them.

None of those questions is about absorbency, and that is the point. In a dual-market file the product performance evidence and the regulatory evidence are separate documents, and a buyer who has been given a capacity figure and a case price has been given neither of the regulatory answers.

Question to the supplier Document that answers it What a good answer looks like
Which regulation classifies the product in the US? Device listing record Class I, 21 CFR 876.5920, no 510(k)
Who is the US agent? Registration record under 807.40 A named US entity with an address
Who holds the Canadian establishment licence? MDEL number and holder name A licence number tied to the importing or distributing entity
Which label applies in each market? Label artwork per market Two labels, each with the required content
What records survive the QMSR exemption? Records and complaint procedure Complaint file with a defined retention period

Detail view of the CliniEco brief construction, the product the two regulatory files describe

Does the comparison change the purchasing specification?

It adds three lines and removes one. The lines it adds are the device classification with its citation, the establishment licence number of the importing or distributing party, and the label version supplied in each market. The line it removes is the demand for a 510(k) number, which does not exist for this device type and which a supplier may be tempted to substitute with a different device's clearance.

The absorbency specification itself is unaffected by either regime, because neither country sets a federal performance standard for adult briefs. ISO 15621:2017 gives guidelines for evaluating absorbent incontinence aids and is useful for comparing products across suppliers, but it is an evaluation framework rather than a regulatory threshold in either market. What protects a facility in both countries is the specification it writes, the receiving check it performs, and the complaint file it keeps — which, in the United States, is one of the few quality obligations that survives the 876.5920 exemption.

CliniEco Day Pro 4,000 mL adult brief, a Class I device in both the United States and Canada

What is different in how the two regulators treat records?

The US position for this device type is unusually light on quality system requirements and unusually specific about what survives: records and complaint files under 820.35. The Canadian position is not a quality system exemption at all — it is a class-based licensing structure in which the manufacturer of a Class I device still carries the obligations the regulations attach to manufacturers, including records and complaint handling, and in which the establishment licence holder carries its own obligations for distribution records and recalls.

For a facility, the practical difference is which document to ask for when something goes wrong. In the United States, the complaint file is the document, because it is the one obligation the exemption preserved. In Canada, the establishment licence holder is the traceable party, and the distribution record is what establishes where the affected units went. Where the affected product is the overnight format, the 5,000 mL Night Plus brief, the lot and case count are the fields that matter. A supplier that can produce neither is telling you something about its file even if the product performs.

Ordering for a facility, a care home or a home health agency? Wholesale and multi-site ordering covers account setup and case quantities, and the B2B wholesale collection lists the lines stocked for institutional buyers. Reselling? become a distributor.

Take this further: plan your volumes with the incontinence supply planner, and print the monthly supply checklist to keep with the purchasing file.

CliniEco Medical is a licensed medical device establishment (MDEL #35334).

Related Reading

Frequently Asked Questions

Do adult briefs need a 510(k) in the United States?

No. They are Class I devices under 21 CFR 876.5920 and exempt from premarket notification, subject to the limitations in 876.9. A supplier that offers a 510(k) number for a brief is describing a different device.

Do adult briefs need a device licence in Canada?

No. Section 26 of the Medical Devices Regulations requires a device licence only for Class II, III and IV devices. A Class I device such as an adult brief does not need one.

Then what licence does a Canadian supplier need?

An establishment licence. Section 44(1) prohibits importing or selling a medical device without one, with narrow exemptions for retailers, health care facilities, and a Class I manufacturer that distributes solely through an establishment licence holder.

Is the product exempt from quality system requirements in both countries?

No. The US exemption in 876.5920 is real but preserves records and complaint file obligations under 820.35. Canada applies class-based obligations to manufacturers and separate obligations to the establishment licence holder; it is not a quality system exemption.

Does a Canadian manufacturer exporting to the US need to register with FDA?

Yes. 21 CFR 807.40 requires a foreign establishment manufacturing a device imported or offered for import into the United States to register and list the device, and to designate a United States agent.

Which country sets an absorbency standard?

Neither. There is no federal absorbency performance standard for adult briefs in the United States, and the Canadian regulations do not set one either. ISO 15621:2017 provides evaluation guidelines, not a regulatory threshold.

Does the classification affect whether a nursing home can buy the product?

No. Class I status in both countries means the product is not gated behind a premarket review, so the buying decision turns on the specification, the establishment licence of the seller, and the labelling rather than on a clearance.

Vous travaillez déjà avec des cliniques ? Devenez représentant régional.